ABclonal
PrivateLast Round
Series D
Dec 8, 2021
Total Funding Raised
$284.02M
Company Overview
ABclonal is a biotechnology company that manufactures life science reagents, including antibodies, recombinant proteins, ELISA kits, and molecular biology enzymes, while providing contract research organization (CRO) services for scientific research and diagnostic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ABclonal Comparables
Compare ABclonal with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cell Signaling Technology | 83% | |
| Sino Biological Inc. | 83% | |
| Proteintech Group | 82% |
ABclonal Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 8, 2021 | ||||
| Series C | Feb 22, 2021 | ||||
| Series B | Aug 1, 2016 | ||||
| Series A | Mar 1, 2016 |
ABclonal Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Loyal Valley Capital | Series D |
| Oriza FOFs | Series C |
| LYFE Capital | Series C |
| C&D Emerging Industry Equity Investment | Series C |
| Beijing Taikang Investment Management Co., Ltd. | Series D |
| Sigma Square Capital | Series C |
| HongShan Capital Group (HSG) | Series D, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 22, 2021
$93M round led by LYFE Capital and HongShan.
ABclonal Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ABclonal's valuation, stock price, and market status.
Is ABclonal a public or private company?
ABclonal is a private company.
What is the current stock price of ABclonal?
ABclonal is a private company with no public stock price. No recent secondary market data is available.
How much is ABclonal worth (valuation)?
Valuation information for ABclonal is not publicly available.
Can I buy ABclonal stock?
ABclonal shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ABclonal's last funding round?
ABclonal's most recent funding round was Series D on December 8, 2021.
Who are the main investors in ABclonal?
Key investors in ABclonal include LYFE Capital, HongShan.
Will ABclonal IPO soon?
No public IPO plans have been announced for ABclonal.
How can I track ABclonal secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ABclonal's secondary market activity and sign up for updates.